Zurueck zur Suche

Reporte zur Charge AU3915B

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WI 1 ID 1 GA 1 FL 1 SC 1 ME 1 MA 1 OR 1 CA 1

VAERS 2713232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

schwer
Staat
WI
Alter
64,0
Geschlecht
M
Eingang
13.11.2023
Impfdatum
03.11.2023
Beginn
03.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Chest X-ray normal Computerised tomogram head Cough Echocardiogram abnormal Electrocardiogram T wave abnormal Electrocardiogram ambulatory Fibrin D dimer normal Impaired driving ability Syncope Troponin

Symptomtext

Syncope episode while driving, patient went to Emergency department- arrived there at 1646.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
1,0
Labordaten
Initial work up were unremarkable with troponin of 4 and D-dimer of 0.23. Chest x-ray was grossly unremarkable. EKG revealed sinus rhythm with nonspecific T-wave changes. CT of the head is pending. He was given breathing treatment and IV fluid." The next morning patient had mild symptoms of cough however had no further syncopal episodes. He had an echocardiogram done that did not reveal any etiology of syncope, an ascending aortic aneurysm was seen which was previously visualized on CT in 8/2023. He was discharged with a 7 holter monitor.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2722187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge au3915b

mild
Staat
ID
Alter
67,0
Geschlecht
F
Eingang
11.12.2023
Impfdatum
05.10.2023
Beginn
07.12.2023
Tage bis Beginn
63,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling Rash Rash erythematous Skin warm Rash pruritic Swelling

Symptomtext

Patient reports that after receiving the vaccines her arm developed a red rash, it was swollen and warm to the touch. She went to her doctor and was prescribed a steroid cream. She reported that it helped the swelling and warmth to the touch but the rash remained. She presented to the pharmacy on 12/7 there was a red circular rash on her arm. It did not appear swollen and patient said it was no longer warm to the touch. Patient states it did not itch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2721007

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

mild
Staat
GA
Alter
40,0
Geschlecht
F
Eingang
05.12.2023
Impfdatum
30.11.2023
Beginn
01.12.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure increased Exposure during pregnancy Headache

Symptomtext

35 weeks, 5 days pregnant. EDD: 1/1/24 Elevated blood pressure began 24 hours after vaccination, around 138/70. Normal BP prior to vaccination was about 105/60. Sustained headache for 48 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Prenatal vitamins
Allergien
None
Vorherige Impfungen
-

VAERS 2710622

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge AU3915B

mild
Staat
FL
Alter
76,0
Geschlecht
F
Eingang
07.11.2023
Impfdatum
11.10.2023
Beginn
16.10.2023
Tage bis Beginn
5,0
Dosis
6
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Rash

Symptomtext

headache; rash/ she started breaking out/ she noticed rashes on her arms, trunk of her body, under her breast, in her hair, maybe on her neck, around her knees, on her face but she noticed her joints had the rash too/ She said she noticed a rash on her thumb j; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and RASH (rash/ she started breaking out/ she noticed rashes on her arms, trunk of her body, under her breast, in her hair, maybe on her neck, around her knees, on her face but she noticed her joints had the rash too/ She said she noticed a rash on her thumb j) in a 76-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. AU3915B) for COVID-19 prophylaxis. Co-suspect product included non-company product INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication. The patient had no relevant medical history/conditions, allergy, concomitant diseases and risk factor. The patient had no allergy and no COVID-19 diagnosis. On 11-Oct-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU VACCINE VII) (unknown route) 1 dosage form. On 16-Oct-2023, the patient experienced HEADACHE (headache) and RASH (rash/ she started breaking out/ she noticed rashes on her arms, trunk of her body, under her breast, in her hair, maybe on her neck, around her knees, on her face but she noticed her joints had the rash too/ She said she noticed a rash on her thumb j). At the time of the report, HEADACHE (headache) and RASH (rash/ she started breaking out/ she noticed rashes on her arms, trunk of her body, under her breast, in her hair, maybe on her neck, around her knees, on her face but she noticed her joints had the rash too/ She said she noticed a rash on her thumb j) had not resolved. Concomitant medication not reported. She got both the Spikevax and flu shot on 11 OCT 2023. She was not sure which flu shot she received but says that it was the senior flu shot for ages 65 and older. Initially everything was fine and that she only had a headache which was not a big deal. However, 4-5 days later, around 16 OCT 2023, she started breaking out. They had gone camping and she was in the woods, so she thought they were mosquito bites. But the rash didn't go away, and she started noticing more. She did not have any skin problems otherwise, neither does she have any allergies. She started looking up skin conditions online and from what she can tell, her rash looks like atrophic dermatitis or eczema. She never had a problem with other Moderna COVID-19 vaccines. At most she experienced a headache or sore arm, but that's it. She noticed rashes on her arms, trunk of her body, under her breast, in her hair, maybe on her neck, around her knees. She did not notice in on her face but noticed on joints. She noticed a rash on 2 Nov 2023 on her thumb joint. Treatment medication not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-748243, US-MODERNATX, INC.-MOD-2023-748238 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: The patient had no relevant medical history/conditions, allergy, concomitant diseases and risk factor. The patient had no allergy and no COVID-19 diagnosis.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2701914

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge au3915b

mild
Staat
SC
Alter
71,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
18.10.2023
Beginn
20.10.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site discomfort Vaccination site erythema Vaccination site pruritus Vaccination site warmth

Symptomtext

Patient had gotten a vaccination 2 days prior. Came in to the pharmacy, said that she had been having a warm sensation where she received her two vaccines. The area was red, uncomfortable and itchy. It was not bruised, but diffuse red area she said had become larger the day before. I asked if she had ever had a reaction to a vaccine before, if she had noticed any bruising. She said she had not. I confirmed she didn't have any allergic reaction symptoms (swelling of lips or tongue, SOB, hives). I told her to try to ice it and take an allergy tablet to reverse possible allergic reaction. I followed up with her the next afternoon, she said she did those treatment measures but it remained unchanged. I told her it may take a week or longer for the symptoms to subside, but call us after a week if it was not staying the same or getting better. Patient will monitor and follow up if she things its not improving.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2700882

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

mild
Staat
ME
Alter
54,0
Geschlecht
M
Eingang
24.10.2023
Impfdatum
17.10.2023
Beginn
18.10.2023
Tage bis Beginn
1,0
Dosis
5
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Ear pain Herpes zoster Pain Pain of skin

Symptomtext

After about 24 hours I felt effects from receiving my COVID booster and annual flu shot. Symptoms presented on the right side of my head, mostly in the hairline. The skin was painful without even touching my skin. The pain periodically radiated into my right ear canal. On the fifth day of symptoms unabated and not improving, I sought care from local walk-in facility. The PA quickly diagnosed my condition as shingles. He stated that my shingles became active after my body had experienced stress, including my immune response to receiving two different vaccines. At this writing I am my first course of anti-viral caplets three pills a day for seven days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ear pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Sleep apnea
Andere Medikamente
Sertraline
Allergien
None
Vorherige Impfungen
-

VAERS 2698073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

mild
Staat
MA
Alter
30,0
Geschlecht
F
Eingang
18.10.2023
Impfdatum
17.10.2023
Beginn
18.10.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site mass Injection site pain Injection site warmth

Symptomtext

Less than 24hrs after vaccination I have the following symptoms at the injection site: soreness, oval-shaped red lump underneath skin about 2in long and 1inch wide. Warm to the touch and lightly firm. These symptoms are localized to the upper arm, at injection site. The redness appears to be decreasing as the day goes on.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Mupirocin ointment, Mirena IUD, ibuprofen
Allergien
Erythromycin
Vorherige Impfungen
-

VAERS 2693136

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge AU3915B

mild
Staat
-
Alter
52,0
Geschlecht
M
Eingang
10.10.2023
Impfdatum
04.10.2023
Beginn
04.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Oropharyngeal pain Pruritus Swelling

Symptomtext

itch; swelling; throat was sore; Red; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itch), SWELLING (swelling), OROPHARYNGEAL PAIN (throat was sore) and ERYTHEMA (Red) in a 52-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. AU3915B) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) .5 milliliter. On 04-Oct-2023, the patient experienced PRURITUS (itch), SWELLING (swelling), OROPHARYNGEAL PAIN (throat was sore) and ERYTHEMA (Red). At the time of the report, PRURITUS (itch), SWELLING (swelling), OROPHARYNGEAL PAIN (throat was sore) and ERYTHEMA (Red) was resolving. For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. It was reported that after one hour of vaccination patient experienced symptoms of itch, red swelling, throat was sore. It was unknown if the patient experienced any additional symptoms/events. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2724504

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

gering
Staat
OR
Alter
54,0
Geschlecht
F
Eingang
15.12.2023
Impfdatum
20.11.2023
Beginn
20.11.2023
Tage bis Beginn
0,0
Dosis
5
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Contusion

Symptomtext

2cmx4cm discoloration/bruise lasted 3 weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Contusion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
migraine, HSV2
Andere Medikamente
bupropion valacyclovir medroxyprogesterone estradiol sumatriptan injection emgality injection vitamin D
Allergien
hornet & yellow jacket venom
Vorherige Impfungen
-

VAERS 2711265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

gering
Staat
CA
Alter
69,0
Geschlecht
M
Eingang
07.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

pt already received one dose of Pfizer Comirnaty (10/3/23) and returned to pharmacy and also received Moderna Spikevax (11/7/23). Pt worried over receiving two doses

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2711131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AU3915B

gering
Staat
-
Alter
34,0
Geschlecht
F
Eingang
07.11.2023
Impfdatum
29.09.2023
Beginn
29.09.2023
Tage bis Beginn
0,0
Dosis
5
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abortion spontaneous Maternal exposure during pregnancy

Symptomtext

she had a miscarriage; was pregnant when got the vaccine; This spontaneous retrospective pregnancy case was reported by a patient and describes the occurrence of ABORTION SPONTANEOUS (she had a miscarriage) in a 34-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. AU3915B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 prophylaxis: Moderna (1st Dose, Lot number: 012L20A) on 14-Jan-2021, Moderna (2nd Dose, Lot number: 031M20A) on 05-Aug-2021, Moderna (3rd Dose) on 22-Oct-2021, Moderna Bivalent (4th Dose and Lot number: AS7140C) on 06-Sep-2022; for Product used for unknown indication: Flu Shot (one week ago). Past adverse reactions to the above products included No adverse event with Flu Shot, Moderna, Moderna, Moderna and Moderna Bivalent. On 29-Sep-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) .5 milliliter. Last menstrual period and estimated date of delivery were not provided. On 29-Sep-2023, after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (was pregnant when got the vaccine). On 01-Nov-2023, the patient experienced ABORTION SPONTANEOUS (she had a miscarriage) (seriousness criterion medically significant). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 29-Sep-2023, MATERNAL EXPOSURE DURING PREGNANCY (was pregnant when got the vaccine) had resolved. At the time of the report, ABORTION SPONTANEOUS (she had a miscarriage) outcome was unknown. For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were provided. Company Comment: This Spontaneous case describes the occurrence of maternal exposure during pregnancy in a 34-years-old female patient, with no relevant medical history, who experienced the unexpected and serious (due to medically significant) event of Abortion spontaneous, which occurred approximately 1 month after SPIKEVAX 2023-2024, administered as fifth dose within COVID-19 vaccination schedule, at unknown weeks of gestation. No information disclosed about diagnostic tests performed or treatments received. The benefit-risk relationship of SPIKEVAX 2023-2024 vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2023: Live significant follow-up received contains historical vaccines added, suspect drug information updated, event added.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abortion spontaneous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-